📋 ATARA BIOTHERAPEUTICS, INC. (ATRA) - Clinical Trial Update
Filing Date: 2026-05-07
Accepted: 2026-05-07 08:10:18
Event Type: Clinical Trial Update
Event Details:
ATARA BIOTHERAPEUTICS, INC. (ATRA) Announces Clinical Trial Update
ATARA BIOTHERAPEUTICS, INC. (ATRA) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: leader, conducted
Diseases/Conditions: a pre-specified manner
Clinical Stage: Phase 3
Collaboration: ALLELE
🔬 Clinical Development Pipeline (ATARA BIOTHERAPEUTICS, INC.):
Product
Type
Development Stage
Therapeutic Area
Source
Placebo
Other
Phase PHASE1
Primary Progressive Multiple Sclerosis
ClinicalTrials.gov
ATA188
Other
Phase PHASE1
Primary Progressive Multiple Sclerosis
ClinicalTrials.gov
Cytomegalovirus-specific Cytotoxic T Lymphocytes (CMV-CTLs)
Other
Preclinical
CMV Viremia
ClinicalTrials.gov
CMV-pp65 CTLs
Other
Phase PHASE2
Cytomegalovirus
ClinicalTrials.gov
EBV-specific T cells (EBV-CTLs)
Other
Phase PHASE2
EBV-induced Lymphomas
ClinicalTrials.gov
tabelecleucel
Other
Preclinical
Epstein-Barr Virus (EBV) Infections
ClinicalTrials.gov
Pembrolizumab
Other
Phase PHASE1
Nasopharyngeal Carcinoma
ClinicalTrials.gov
ATA3219
Other
Phase PHASE1
Lupus Nephritis
ClinicalTrials.gov
CAR T cells
Other
Phase PHASE1
Malignant Pleural Mesothelioma (MPM)
ClinicalTrials.gov
cyclophosphamide
Other
Phase PHASE1
Malignant Pleural Mesothelioma (MPM)
ClinicalTrials.gov
WT1-sensitized T cells
BIOLOGICAL
Phase PHASE1
Leukemia
ClinicalTrials.gov
Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)
📋 ATARA BIOTHERAPEUTICS, INC. (ATRA) - Clinical Trial Update
Filing Date: 2026-05-07
Accepted: 2026-05-07 08:10:18
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (ATARA BIOTHERAPEUTICS, INC.):
💼 Business Developments:
Structured Data: